NIDA Notes Articles: Pregnant Women

Sort by:
Date
|
Title

Research Focuses on Groups With High Smoking Rates

April 2012
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Women and Sex/Gender Differences Research Program

April 2012
NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Buprenorphine During Pregnancy Reduces Neonate Distress

July 2012
Sublingual buprenorphine is a safe and effective alternative to methadone for treating opioid dependence during pregnancy, finds the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a NIDA-supported clinical trial. Women who received either medication had similar pregnancy and birth outcomes, but infants born to women who received buprenorphine had milder symptoms of neonatal opioid withdrawal.

Prenatal Methamphetamine Exposure Linked With Problems

December 2012
Study findings indicate that children exposed to methamphetamine prenatally show more signs of increased emotionality, anxiety, and depression than nonexposed children at ages 3 and 5 years.

Menu

Research Focuses on Groups With High Smoking Rates

Women and Sex/Gender Differences Research Program

Buprenorphine During Pregnancy Reduces Neonate Distress

Prenatal Methamphetamine Exposure Linked With Problems

Pages

Categories

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics